Chinese Stocks To Keep An Eye On - October 10th

Key Points

• Chinese stocks currently in focus include Diageo, UP Fintech, Regencell Bioscience, Universe Pharmaceuticals, and BGM Group, all of which saw the highest trading volumes recently.
• Diageo specializes in producing a wide range of alcoholic beverages, offering over 50 brands across various categories including whiskey and wine.
• Regencell Bioscience is focused on Traditional Chinese Medicine aimed at treating neurocognitive disorders, while Universe Pharmaceuticals develops products for elderly health and common chronic conditions.

Diageo, UP Fintech, Regencell Bioscience, Universe Pharmaceuticals, and BGM Group are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities issued by companies incorporated in mainland China or Hong Kong and traded on exchanges such as Shanghai, Shenzhen or the Hong Kong Stock Exchange (as well as overseas markets via instruments like U.S.-listed ADRs). They include different share classes—A-shares (yuan-denominated, mainland exchanges), H-shares (Hong Kong–listed) and others—and offer investors exposure to China’s economic growth, albeit with unique regulatory, currency and market-access considerations. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.

Read Our Latest Research Report on UPC

BGM Group (BGM)

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.

Read Our Latest Research Report on BGM